Positive preliminary results of an ongoing, first-in-human Phase 1/2 study demonstrating that stem cell-derived therapy can produce insulin in people with severe type 1 diabetes were published today in Cell Stem Cell and Cell Reports Medicine. “The data from these papers represent a significant scientific advance,” said Cell Reports Medicine study lead author James Shapiro, MD PhD, Canada […]
